Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)

Clinical trial NCT06151197 · COMPLETED

Trial details

NCT number: NCT06151197
Sponsor: Endo USA Inc., a Keenova Therapeutics Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Plantar Fibromatosis Ledderhose Disease

Start date: 2023-11-28
Primary completion: 2026-06-09
Enrollment: 436

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.